Omalizumab is effective in symptomatic dermographism—results of a randomized placebo-controlled trial

Title
Omalizumab is effective in symptomatic dermographism—results of a randomized placebo-controlled trial
Authors
Keywords
-
Journal
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 140, Issue 3, Pages 870-873.e5
Publisher
Elsevier BV
Online
2017-04-05
DOI
10.1016/j.jaci.2017.01.042

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started